It may increase in patients with malignant tumors, for example, the combined detection of CRP and AFP were used in the differential diagnosis of hepatocellular carcinoma and benign liver diseases, and in the judgment of the efficacy and prognosis of liver cancer. This evidence concerns the gene AFP and hepatocellular carcinoma.